Triple-action weekly diabetes jab shows promise in reducing blood sugar and body weight
1 unrated
Phase 3 trial results indicate that a new triple-action weekly injection for type 2 diabetes can significantly lower blood sugar levels and body weight. Patients receiving the retatrutide injections lost more than four times as much weight compared to those on placebo, with an average drop in HbA1c twice that of the placebo group.
What each source uniquely contributed
- The Guardian unrated — Weekly retatrutide injections for type 2 diabetes could significantly reduce blood sugar and body weight, according to phase 3 trial results.